Genespire Revenue and Competitors

Location

$69M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Genespire's estimated annual revenue is currently $2.6M per year.(i)
  • Genespire's estimated revenue per employee is $155,000
  • Genespire's total funding is $69M.

Employee Data

  • Genespire has 17 Employees.(i)
  • Genespire grew their employee count by 13% last year.

Genespire's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Genespire?

Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners.

keywords:N/A

$69M

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M17-11%N/A
#2
$1.1M176%$4.4M
#3
$1.5M17N/AN/A
#4
$3.1M17N/AN/A
#5
$2.1M17N/AN/A